Delivery Order SPE2DB25D3404-SPE2DB25FUPKR
- Not listed
- The Defense Logistics Agency awarded a $11,425.14 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with completion targeted for July 15, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products, with a ceiling value of $2,202.89. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under...
- The Defense Logistics Agency awarded a $4,190.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,764.09 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication used to treat growth disorders and related conditions. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,295.52 for Norditropin FlexPro 10 mg/1.5 ml on May 28, 2025, with completion scheduled for May 29, 2025. This competitive, non-set-aside award was made under a firm fixed price contract type for pharmaceutical delivery to the Conshohocken, Pennsylvania location. The delivery order represents a child contract action under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency has awarded a delivery order valued at $2,432.40 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product. This firm fixed price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract action under the company's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.69 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPKRDelivery Order
The Defense Logistics Agency awarded a $4,190.76 delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for military and veteran healthcare systems through its comprehensive IDC vehicle, which enables supply of brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The current delivery order for Norditropin, a growth hormone treatment, exemplifies the company's role in supplying specialized pharmaceutical products to federal customers. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/23/25 |